CD8A and neoplasm: Studies in humans with a clinical cancer diagnosis have shown that prognosis is more strongly associated with tumour-infiltrating CD8+ T cells expressing tissue-residency marker CD103+ than total tumour-infiltrating CD8+ T cells (180, 181).